INTRODUCTION AND OBJECTIVES: Bladder cancer is the 4th most common malignancy in the US but only 2-5% have squamous cell carcinoma (SCC). Neoadjuvant chemotherapy (NAC) is well established for muscle invasive urothelial carcinoma (MI-UC). Its role in SCC
has not been directly studied but is an important question given the tendency of SCC for muscle-invasion at diagnosis. We used the National Cancer Database (NCDB) to explore survival in patients undergoing radical cystectomy (RC) AE NAC for MI-SCC.
METHODS: We queried the NCDB for diagnoses of either UC or SCC using ICD-0-3 morphologic codes from cases reported between 2004 and 2015. Outcomes of interest were overall survival (OS) and pathologic complete response (pT0) in cT2-4N0M0 muscle invasive bladder cancer (MIBC) who underwent radical cystectomy (RC). NAC was defined as chemotherapy start date <120 days prior to RC. For all statistical measures, p<0.05 considered statistically significant.
RESULTS: There were 394,979 bladder cancer patients identified, of which histology was SCC in 1. 4% (n[4,783) . MIBC at presentation was more likely in SCC than UC (70% v. 19%, p<0.01) . A total of 21,233 patients had RC for cT2-4N0M0. NAC was more common for UC than SCC (19% v. 7%, p<0.01). The proportion of patients with pT0 was higher with NAC compared to RC alone in both groups: SCC (7.5% v. 1%; p<0.01) and UC (14.0% v. 4.0%; p<0.01). Predictors of pT0 status included SCC (OR 0.42, 95% CI 0.24-0.74, p<0.01) and use of NAC (OR 3.72, 95% CI 3.29-4.22, p<0.01, Table) . NAC significantly improved survival (HR 0.81, 95% CI 0.77-0.86, p<0.01) over RC alone for UC but not SCC (HR 0.93, p[0.69) .
CONCLUSIONS: Patients with SCC are far more likely to present with MIBC, though utilization of NAC is lower than UC. NAC improved the pT0 status for both SCC and UC but did not impart a survival benefit in the former. Though NAC is the current standard treatment for cT2-4N0M0 bladder cancer, SCC will require a different approach to improve outcomes. METHODS: We performed a retrospective cohort study using the National Cancer Database (2006 Database ( -2014 and identified 1869 cT2-4N1-3M0 bladder cancer patients treated with (1) radical cystectomy (RC), (2) neoadjuvant chemotherapy (NAC) þ RC, (3) adjuvant chemotherapy (AC) þ RC, (4) radiation þ chemotherapy, (5) chemotherapy alone, or (6) no treatment/palliative care only. The primary outcome was survival by treatment, analyzed using KaplanMeier and multivariable Cox-proportional hazards regression. Secondary outcomes included pathologic down-staging, analyzed using univariable/multivariable logistic regression models. A univariable logistic regression model of treatment by year was used to identify treatment trends. Multivariable models were adjusted for confounding demographic, facility, and clinicopathologic variables.
RESULTS: Among 1869 patients (cN1, 48%; cN2, 44%; cN3 8%), 567 underwent RC, 418 underwent NAC, 591 underwent AC, 61 underwent radiation þ chemotherapy, 136 underwent chemotherapy alone, and 96 had no definitive treatment. Overall survival did not differ between NAC and AC, but both had improved survival compared to RC alone. All other treatment groups had worse survival outcomes in comparison to NAC. When comparing NAC to RC alone, down-staging to pT0 (adjusted odds ratio [aOR] [26.39) and pN0 (aOR[6.88) was higher for NAC. Overall, utilization of NAC and no treatment has increased, use of AC and RC alone has declined, and use of chemotherapy and radiation without surgery has not changed.
CONCLUSIONS: Combined chemotherapy and RC is associated with improved outcomes for LNþ bladder cancer compared to RC or chemotherapy alone, although there is no significant difference between NAC and AC. Use of radiation and chemotherapy without RC has stayed consistent and is associated with worse oncologic outcomes compared to RC with perioperative chemotherapy, but no significant difference compared to RC or chemotherapy alone. Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e925
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